SHENZHEN, China, Oct. 05, 2025 (GLOBE NEWSWIRE) -- XPPen, a global leader in digital art innovation, unveils its Prime Big…
Of the 209 patients with tardive dyskinesia (TD) that were surveyed, >94% reported movement improvement once treated with AUSTEDO XR®…
FLORHAM PARK, N.J., June 06, 2025 (GLOBE NEWSWIRE) -- Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT) today announced that the U.S. Food…